Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

Ítems similars

• Scoring mechanisms of p16(INK4a )immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study
  per: Koo, Chiew-Loon, et al.
  Publicat: (2009)
• DISTINGUISHING FEATURES OF ENDOMETRIAL PATHOLOGY FOLLOWING EXPOSURE TO THE PROGESTERONE RECEPTOR MODULATOR MIFEPRISTONE
  per: Fiscella, Julietta, et al.
  Publicat: (2011)
• Progesterone Receptor Action in Leiomyoma and Endometrial Cancer
  per: Kim, J. Julie, et al.
  Publicat: (2009)
• Progesterone receptor gene variants and risk of endometrial cancer
  per: O'Mara, Tracy A., et al.
  Publicat: (2011)
• Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
  per: Kreizman-Shefer, Hila, et al.
  Publicat: (2014)